Filing Flows › ICU Medical (ICUI) › Guidance history
ICU Medical (ICUI) guidance history: what it guided and what it reported
ICU Medical gave guidance in 10 earnings releases on file since Feb 27, 2024. Its releases raised guidance 6 times and lowered it 3 times.
GAAP net income
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $26.0M–$44.0M (Feb 19, 2026) → raised $73.0M–$83.0M (Aug 6, 2026) → reaffirmed $73.0M–$83.0M (Nov 5, 2026) | — | to be reported | — |
| FY2025 | −$45.0M–−$28.0M (Feb 27, 2025) → lowered −$43.0M–−$35.0M (Aug 7, 2025) → raised −$8.0M–$0 (Nov 6, 2025) | — | — | — |
GAAP EPS
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $1.03–$1.74 (Feb 19, 2026) → raised $2.89–$3.29 (Aug 6, 2026) → reaffirmed $2.89–$3.29 (Nov 5, 2026) | — | to be reported | — |
| FY2025 | −$1.81–−$1.11 (Feb 27, 2025) → lowered −$1.68–−$1.38 (Aug 7, 2025) → raised −$0.30–$0.00 (Nov 6, 2025) | — | — | — |
| FY2024 | −$3.57–−$2.87 (Feb 27, 2024) → lowered −$4.78–−$4.38 (Aug 7, 2024) → lowered −$5.28–−$4.98 (Nov 12, 2024) | — | — | — |
Capital expenditures
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $75.0M (Nov 5, 2026) | — | to be reported | — |
Adjusted EBITDA
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $400M–$430M (Feb 19, 2026) → raised $415M–$435M (Aug 6, 2026) → reaffirmed $415M–$435M (Nov 5, 2026) | — | to be reported | — |
| FY2025 | $395M–$425M (Feb 27, 2025) → lowered $380M–$390M (Aug 7, 2025) → raised $395M–$405M (Nov 6, 2025) | — | — | — |
| FY2024 | $330M–$370M (Feb 27, 2024) → raised $345M–$365M (Aug 7, 2024) → raised $355M–$365M (Nov 12, 2024) | — | — | — |
Adjusted EPS
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $7.75–$8.45 (Feb 19, 2026) → raised $8.60–$9.00 (Nov 5, 2026) | — | to be reported | — |
| FY2025 | $6.55–$7.25 (Feb 27, 2025) | — | — | — |
| FY2024 | $4.40–$5.10 (Feb 27, 2024) | — | — | — |
The latest quarter
ICU Medical, Q3 2026: revenue $560M (+4% year over year), operating margin 9.3%, net earnings $26.8M, operating cash flow $99.6M. The chart follows the revenue to costs, profit and cash.
Questions
Does ICU Medical beat its guidance?
ICU Medical gave guidance in 10 earnings releases on file since Feb 27, 2024. Its releases raised guidance 6 times and lowered it 3 times.
How often does ICU Medical raise guidance?
Its earnings releases raised guidance 6 times and lowered it 3 times since Feb 27, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.